Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial oxidoreductase enzymes are a diverse group of enzymes (classified in EC 1) that catalyze redox reactions—electron transfer between molecules—essential for cellular metabolism, energy production, and detoxification in bacteria. They comprise various families (dehydrogenases, reductases, oxidases, peroxidases, oxygenases, catalases) and show wide structural and mechanistic diversity, employing cofactors such as NAD/NADP, FMN, FAD, Heme, or metal ions. They are widespread in bacterial species, with some subclasses unique to bacteria or archaea (e.g., certain Mn-catalases and DMSO/molybdopterin oxidoreductases). Their functional roles include core metabolism, adaptation to stress, and, in some bacteria, alternative energy production. As therapeutic targets, they are recognized for roles in infection (bacterial viability and antibiotic resistance), and as industrial biocatalysts, they are valued for oxidation, reduction, and detoxification processes under extreme conditions. The term is an umbrella for hundreds of distinct enzymes, each with specialized substrates, cofactors, and disease or biotechnology importance.
Inhibition of electron transfer/metabolic pathway activity; Generation of reactive oxygen species (ROS); Interference with substrate binding or cofactor utilization (NAD/NADP, FMN, FAD, Heme, Iron-sulfur cluster); Modification or destruction of bacterial energy metabolism
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial oxidoreductase enzyme (None established; abbreviated generally as “oxidoreductase” or by specific enzyme (e.g., “MDH” for methanol dehydrogenase), but no universal abbreviation for the broad class).